开立医疗收盘下跌1.14%，滚动市盈率275.90倍，总市值138.73亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Kaili Medical, indicating a significant decline in revenue and profit in the first quarter of 2025 compared to the previous year [1][2] - As of July 31, Kaili Medical's stock closed at 32.06 yuan, with a rolling PE ratio of 275.90 times, and a total market capitalization of 13.873 billion yuan [1] - The average PE ratio for the medical device industry is 54.89 times, with a median of 37.06 times, positioning Kaili Medical at 118th in the industry ranking [1][2] Group 2 - In Q1 2025, Kaili Medical reported an operating income of 430 million yuan, a year-on-year decrease of 10.29%, and a net profit of 8.0746 million yuan, down 91.94% year-on-year, with a gross profit margin of 63.19% [2] - The company specializes in the research, development, production, and sales of medical diagnostic and treatment equipment, with key products including ultrasound diagnostic devices, endoscopes, minimally invasive surgical products, and cardiovascular intervention products [1] - Kaili Medical has over 20 years of experience in the ultrasound industry, being one of the first domestic companies to develop and master core technologies for color ultrasound machines and probes, achieving a strong market presence with a second-place market share among domestic manufacturers and a tenth-place share globally [1]